Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

Also called NCT04926623

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 159 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04926623
Other papers using this trial's data
  • Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial Diabetologia, 2024-07 DOI, PubMed 38639876

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04926623. Randomized; no masking; primary purpose health services research. Start 2021-06-17 (actual); primary completion 2022-10-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
FreeStyle Libre 24 weeks
Intervention (Other)
SMBG (22 weeks) and blind CGM (2 weeks)
Lead sponsor
Daewoong Pharmaceutical Co. LTD. (class: industry)

Record details

Record id
cardio:ct-nct04926623
Content hash
e2dda8f03cdf87c3c09834a8c8bac2ea00d7a8f9100394fb67311d787f01bbe9